Emcure Pharmaceuticals Limited — Others, 07-02-2025: Action(s) initiated or orders passed

Emcure Pharmaceuticals Limited’s subsidiary, Zuventus Healthcare, has received an order from the Deputy Commissioner of CGST & Central Excise confirming a tax demand of ₹61.33 crore along with applicable interest and the same amount as a penalty for the fiscal year 2017-18. While this order may raise concerns, Emcure stated that it does not foresee a material impact on its financial or operational activities, as Zuventus plans to appeal. Investor sentiment may remain steady in light of the company's proactive approach in addressing the matter, although vigilance regarding potential legal expenses is advised.